News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
362,807 Results
Type
Article (14410)
Company Profile (116)
Press Release (348281)
Section
Business (112609)
Career Advice (456)
Deals (18609)
Drug Delivery (28)
Drug Development (31162)
Employer Resources (49)
FDA (8790)
Job Trends (7670)
News (172716)
Policy (12353)
Tag
Academia (1318)
Alliances (34750)
Alzheimer's disease (488)
Approvals (8798)
Artificial intelligence (209)
Bankruptcy (130)
Best Places to Work (6522)
Biotechnology (87)
Breast cancer (100)
Cancer (852)
Career advice (406)
CAR-T (91)
Cell therapy (240)
Clinical research (24306)
Collaboration (513)
Compensation (90)
COVID-19 (1139)
C-suite (106)
Data (794)
Diabetes (82)
Diagnostics (4873)
Drug discovery (66)
Earnings (38309)
Events (50902)
Executive appointments (333)
FDA (9278)
Funding (409)
Gene editing (71)
Gene therapy (151)
GLP-1 (212)
Government (1229)
Healthcare (9880)
Infectious disease (1206)
IPO (7992)
Job creations (1434)
Job search strategy (362)
Layoffs (114)
Legal (2518)
Lung cancer (105)
Manufacturing (151)
Medical device (11420)
Medtech (11425)
Mergers & acquisitions (10893)
Metabolic disorders (182)
Neuroscience (647)
NextGen: Class of 2025 (3534)
Non-profit (1520)
Northern California (940)
Obesity (80)
Opinion (75)
Patents (111)
People (32569)
Phase I (8975)
Phase II (10971)
Phase III (7109)
Pipeline (372)
Postmarket research (501)
Preclinical (4033)
Radiopharmaceuticals (153)
Rare diseases (124)
Real estate (3356)
Regulatory (9266)
Research institute (1267)
Resumes & cover letters (68)
Series A (76)
Southern California (1002)
Startups (2504)
United States (9878)
Vaccines (288)
Date
Today (103)
Last 7 days (429)
Last 30 days (1471)
Last 365 days (18187)
2025 (2937)
2024 (18711)
2023 (22098)
2022 (30813)
2021 (32512)
2020 (30538)
2019 (25793)
2018 (19458)
2017 (18871)
2016 (17761)
2015 (20560)
2014 (15177)
2013 (12742)
2012 (13781)
2011 (14066)
2010 (12826)
Location
Africa (318)
Arizona (110)
Asia (23905)
Australia (4163)
California (2435)
Canada (933)
China (198)
Colorado (144)
Connecticut (120)
Europe (48840)
Florida (400)
Georgia (116)
Illinois (247)
Indiana (141)
Japan (87)
Kansas (79)
Maryland (406)
Massachusetts (1725)
Michigan (173)
Minnesota (222)
New Jersey (765)
New York (716)
North Carolina (477)
Northern California (940)
Ohio (92)
Pennsylvania (499)
South America (504)
Southern California (1002)
Texas (383)
Utah (92)
Washington State (291)
362,807 Results for "riverain technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Riverain Technologies ClearRead™ CT Selected by the VA’s Lung Precision Oncology Program for Early Lung Cancer Detection
Riverain Technologies, the pioneer of Clear Visual Intelligence™ for chest imaging interpretation, was selected by the Veterans Health Administration to provide its unique imaging interpretation solution, ClearRead™ CT, to the Veteran Affair’s Lung Precision Oncology Program.
November 15, 2022
·
3 min read
BioMidwest
Riverain Technologies™ Expands Partnerships for Automated, Efficient End-to-End Lung Cancer Screening Capabilities
Riverain Technologies ™ Expands Partnerships for Automated, Efficient End-to-End Lung Cancer Screening Capabilities.
November 23, 2021
·
2 min read
BioMidwest
Riverain Technologies™ will Showcase Enhancements to its AI Platform for Lung Nodule Detection at RSNA
Riverain Technologies™, a leader in artificial intelligence (AI) for early, efficient detection of lung nodules, will showcase its solutions and enhancements at the 107th Annual Radiological Society of North America (RSNA) meeting.
November 29, 2021
·
2 min read
Business
Imbio and Riverain Technologies Partner to Offer a Comprehensive AI-Powered Lung Health Solution
Imbio, a leading medical imaging artificial intelligence (AI) provider for chronic lung and cardiothoracic diseases, and Riverain Technologies™, a leader in clinical AI for lung nodules, announce a partnership to deliver a more complete lung health solution for clinicians, health systems, and radiology practices
May 18, 2021
·
3 min read
Press Releases
Silq Technologies Corp. and NuSil Technology LLC Announce Collaboration Agreement to Drive Broad-based Adoption of Silq’s Novel Surface Treatment Technology
February 19, 2025
·
3 min read
Artificial intelligence
FDA’s New AI Guidance Highlights Risks of Technology, Urges Early Sponsor Engagement
The FDA’s guidance on AI in drug development points to potentially life-threatening consequences of the technology, highlighting the importance of providing the regulator with detailed information regarding models’ development and maintenance.
January 7, 2025
·
2 min read
·
Tristan Manalac
BioMidwest
LucidHealth™ and Riverain™ Technologies Are Committed to the Delivery of Advanced Radiology Through Artificial Intelligence
LucidHealth, a physician-owned and led radiology company, announced today that it is using FDA-approved ClearRead™ CT by Riverain Technologies, an artificial intelligence (AI) imaging software solution for the early detection of lung disease.
April 14, 2020
·
2 min read
Press Releases
Hemostemix Licenses CytoImmune’s BioReactor Technologies
February 19, 2025
·
9 min read
Press Releases
Tevogen Bio Meets BARDA TechWatch Team, Highlighting ExacTcell™ Technology’s Potential as a Scalable Medical Countermeasure
February 9, 2025
·
2 min read
Press Releases
RETRANSMISSION: Hemostemix Licenses CytoImmune’s BioReactor Technologies
February 20, 2025
·
9 min read
1 of 36,281
Next
